Rabbit Polyclonal Glycogen synthase 2 antibody. C-terminal. Suitable for IHC-P, WB and reacts with Human samples. Immunogen corresponding to Recombinant Fragment Protein within Human GYS2 aa 600 to C-terminus.
IgG
Rabbit
pH: 7.2
Preservative: 0.02% Sodium azide
Constituents: PBS, 40% Glycerol (glycerin, glycerine)
Liquid
Polyclonal
IHC-P | WB | |
---|---|---|
Human | Tested | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/200.00000 - 1/500.00000 | Notes Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 0.04000-0.40000 µg/mL | Notes - |
Glycogen synthase participates in the glycogen biosynthetic process along with glycogenin and glycogen branching enzyme. Extends the primer composed of a few glucose units formed by glycogenin by adding new glucose units to it. In this context, glycogen synthase transfers the glycosyl residue from UDP-Glc to the non-reducing end of alpha-1,4-glucan.
Glycogen synthase 2, GYS2
Rabbit Polyclonal Glycogen synthase 2 antibody. C-terminal. Suitable for IHC-P, WB and reacts with Human samples. Immunogen corresponding to Recombinant Fragment Protein within Human GYS2 aa 600 to C-terminus.
IgG
Rabbit
pH: 7.2
Preservative: 0.02% Sodium azide
Constituents: PBS, 40% Glycerol (glycerin, glycerine)
Liquid
Polyclonal
Affinity purification Immunogen
Blue Ice
1-2 weeks
+4°C
-20°C
Upon delivery aliquot
Avoid freeze / thaw cycle
Abcam is leading the way to address reproducibility in scientific research with our highly validated recombinant monoclonal and recombinant multiclonal antibodies. Search & select one of Abcam's thousands of recombinant alternatives to eliminate batch-variability and unnecessary animal use.
If you do not find a host species to meet your needs, our catalogue and custom Chimeric range provides scientists the specificity of Abcam's RabMAbs in the species backbone of your choice. Remember to also review our range of edited cell lines, proteins and biochemicals relevant to your target that may help you further your research goals.
Abcam antibodies are extensively validated in a wide range of species and applications, so please check the reagent specifications meet your scientific needs before purchasing. If you have any questions or bespoke requirements, simply visit the Contact Us page to send us an inquiry or contact our Support Team ahead of purchase.
This supplementary information is collated from multiple sources and compiled automatically.
Glycogen synthase 2 (GYS2) also known as liver glycogen synthase is an enzyme that plays an important role in glycogen synthesis by converting UDP-glucose into glycogen. It possesses a molecular mass of approximately 79.8 kDa. This enzyme is highly expressed in liver tissues. GYS2 is responsible for the formation of the α-14-glycosidic linkages critical for the elongation of glycogen branches and utilizes UDP-glucose as a substrate.
Glycogen synthase 2 facilitates the storage of glucose as glycogen in the liver. It is not part of a complex but works alongside other enzymes in the glycogenic process to regulate glucose homeostasis in the body. GYS2 activity gets regulated through allosteric interactions and phosphorylation responding to energy needs of the cell. Its function is instrumental in maintaining proper blood glucose levels especially postprandially when blood glucose rises.
Glycogen synthase 2 is integral to the glycogen metabolism pathway. It operates synergistically with other proteins such as glycogen phosphorylase and glycogen-branching enzyme during the synthesis and breakdown of glycogen. GYS2 is also influenced by signaling pathways including the insulin signaling pathway which modulates its activity through phosphorylation. Insulin levels directly impact the enzyme leading to storage or release of glucose based on the body’s energy demands.
There is a strong link between glycogen synthase 2 and glycogen storage disease type 0 (GSD 0). Mutations in the GYS2 gene impair glycogen synthesis resulting in hypoglycemia and hepatomegaly due to insufficient glycogen storage in the liver. Additionally GYS2 alterations may contribute to type 2 diabetes as disturbed glycogen synthesis can affect glucose homeostasis. Insulin-resistant conditions show a decreased activation of GYS2 highlighting its connection with key metabolic disorders.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
All lanes: Western blot - Anti-Glycogen synthase 2 antibody - C-terminal (ab224552) at 1/100 dilution
Lane 1: RT4 (human urinary bladder cancer cell line) cell lysate
Lane 2: U-251 MG (human brain glioma cell line) cell lysate
Lane 3: Human plasma
Lane 4: Human liver tissue lysate
Lane 5: Human tonsil tissue lysate
Developed using the ECL technique.
Predicted band size: 81 kDa
Paraffin-embedded human liver tissue stained for Glycogen synthase 2 using ab224552 at 1/200 dilution in immunohistochemical analysis.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com